000			02368cam a2200445 a 4500
999			_c987 _d987
001			14797086
005			20181209101816.0
008			070403s2007 njua b 001 0 eng
010			_a 2007013738
020			_a9789812705761 (hardcover)
020			_a9812705767 (hardcover)
020			_a9789812707789 (pbk.)
020			_a9812707786 (pbk.)
035			_a(DNLM)101303623
040			_aDNLM/DLC _cDLC _dDLC
050	0	0	_aRM171.7 _b.C478 2007
060	1	0	_aWH 450 _bC456a 2007
082	0	0	_a615.39 _222
100	1		_aChang, Thomas Ming Swi.
245	1	0	_aArtificial cells : _bbiotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy / _cThomas Ming Swi Chang.
250			_a1st ed
260			_aHackensack, N. J. : _bWorld Scientific, _cc2007.
300			_axxvi, 455 p. : _bill. (some col.) ; _c24 cm.
440		0	_aRegenerative medicine, artificial cells and nanomedicine ; _vv. 1
504			_aIncludes bibliographical references (p. 377-440).
505	0		_a50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research.
650		0	_aArtificial cells.
650		0	_aBlood substitutes.
650		0	_aNanotechnology.
650	1	2	_aBlood Substitutes.
650	2	2	_aBiotechnology.
650	2	2	_aCells.
650	2	2	_aNanomedicine.
650	2	2	_aRegenerative Medicine.
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0715/2007013738.html
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK